‘No Profit’ COVID-19 Drugs By Novartis To Low-Income Countries

Like
Like Love Haha Wow Sad Angry

Novartis’s ‘No Profit’ COVID19 Drugs The Swiss drugmaker, Novartis said on Thursday that Novartis’s Sandoz division is making 15 generic drugs available to developing countries to treat symptoms of COVID-19 and will not make a profit on these 15 generic drugs. To all the 79 countries on the World Bank’s list of low- and lower-middle-income […]

The post ‘No Profit’ COVID-19 Drugs By Novartis To Low-Income Countries appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/07/novartiss-no-profit-covid19-drugs-to-low-income-countries/

Like
Like Love Haha Wow Sad Angry